Related Experiment Videos
[Changes in perimetric defects in chronic open-angle glaucoma studied by automated perimetry (Octopus)]
Journal Francais D'Ophtalmologie
|January 1, 1985
Summary
This study introduces a "global value" from Octopus perimetry to monitor chronic open-angle glaucoma visual fields. Initial tests showed improvement, possibly due to patient learning, highlighting the need for careful interpretation of glaucoma progression.
Area of Science:
- Ophthalmology
- Visual Science
- Medical Technology
Background:
- Chronic open-angle glaucoma (COAG) is a progressive optic neuropathy.
- Accurate monitoring of visual field changes is crucial for managing COAG.
- Existing methods may have limitations in detecting subtle paracentral visual field degradation.
Purpose of the Study:
- To evaluate the utility of a novel "global value" parameter derived from Octopus perimetry for monitoring visual field changes in COAG patients.
- To establish a reliable numerical parameter for assessing paracentral visual field status.
- To analyze the variability and significance of changes in this "global value" over time.
Main Methods:
- Utilized the Octopus automatic perimeter on 90 patients with COAG.
- Calculated a "global value" using 62 specific test points from program 33, excluding Mariotte's zone and central 10 degrees.
- Performed statistical analysis on "global value" variations between successive examinations.
Main Results:
- A significant improvement in "global value" was observed between the first and second tests.
- This improvement phenomenon disappeared in subsequent tests.
- A degradation of 1 dB between the first two tests and 3 dB in later tests was identified as significant for visual field loss (1% error).
Conclusions:
- The "global value" serves as an effective numerical parameter for monitoring paracentral visual fields in COAG.
- Initial "global value" improvements may be influenced by patient learning or test experience.
- Established thresholds (1 dB/3 dB) for "global value" degradation indicate significant visual field loss in COAG patients.